Journal article
Enhanced passive surveillance of influenza vaccination in England, 2016-2017- an observational study using an adverse events reporting card
- Abstract:
-
Influenza is a major public health burden, mainly prevented by vaccination. Recommendations on influenza vaccine composition are updated annually and constant benefit-risk monitoring is therefore needed. We conducted near-real-time enhanced passive surveillance (EPS) for the influenza vaccine, Fluarix Tetra, according to European Medicines Agency guidance, in 10 volunteer general practices in England using Fluarix Tetra as their principal influenza vaccine brand, from 1-Sep to 30-Nov-2016. Th...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 2.1MB)
-
- Publisher copy:
- 10.1080/21645515.2019.1565258
Authors
Bibliographic Details
- Publisher:
- Taylor and Francis Publisher's website
- Journal:
- Human Vaccines and Immunotherapeutics Journal website
- Volume:
- 15
- Issue:
- 5
- Pages:
- 1048-1059
- Publication date:
- 2019-03-20
- Acceptance date:
- 2018-12-27
- DOI:
- EISSN:
-
2164-554X
- ISSN:
-
2164-5515
- Pmid:
-
30648923
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:1013691
- UUID:
-
uuid:6758abff-5e4f-4d77-af70-d9d46a98848d
- Local pid:
- pubs:1013691
- Source identifiers:
-
1013691
- Deposit date:
- 2019-11-04
Terms of use
- Copyright holder:
- GlaxoSmithKline
- Copyright date:
- 2019
- Notes:
- © 2019 GlaxoSmithKline Biologicals SA. Published with license by Taylor and Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record